Skip to content

Clinical study on the treatment of mild to moderate acne patients with compound almond acid

Clinical study on the treatment of mild to moderate acne patients with compound almond acid

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125099
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Control group:Single acid is used on the control side
Experimental group:Composite acid is used on the experimental side

Sponsors

Henan Provincial People's Hospita,medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1.Sign the informed consent form, commit to following the research procedures, and cooperate in implementing the entire research process; 2.Age 12-50 years old, male or female, good health condition; 3.Diagnosed with mild to moderate acne, in accordance with the Chinese Acne Treatment Guidelines (2024 Edition), grades I-II; 4.Acne patients have at least 10 active skin lesions; 5.Agree not to use facial products of the same category as the test sample during the trial period; 6.Agree not to use any cosmetics, drugs, or health products that may affect the results during the trial period (except for the commitment to maintain daily facial care procedures and use of facial skincare products for the first 2 weeks before the trial period and during the trial period); 7.If it is a female in the reproductive period, she should use contraception for at least one month before screening and commit to using contraception throughout the entire study period until the specified time after the end of the study; 8.Do not participate in any clinical trials at other research centers during the trial period;

Exclusion criteria

Exclusion criteria: 1.Individuals with severe systemic or psychiatric disorders; 2.Individuals who have received systemic therapy such as oral tretinoin, glucocorticoids, and anti melanoma drugs within the past 3 months; 3.Use of acid containing topical medications or medical beauty treatments (such as lasers, fruit acid peels, etc.) in the past 4 weeks; 4.Known allergy history to acidic products; 5.History of skin or other diseases that may affect the test results, as well as other conditions that prevent the use of test samples; 6.I have participated in other clinical trial studies within 3 months prior to the start of this study or currently; 7.Pregnant, breastfeeding, or planning to conceive; 8.In addition to the above matters, according to the judgment of the research leader, it is not suitable to conduct the experiment; 9.Individuals with scar constitution;

Design outcomes

Primary

MeasureTime frame
Non-invasive skin physiological function test;Percentage of Pimple Damage Count;

Secondary

MeasureTime frame
Pain assessment during treatment;Overall facial beauty improvement score;

Countries

China

Contacts

Public ContactLi Xueli

Henan Provincial People's Hospital

13598016866@139.com+86 371 61621996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026